Access to therapy is part of the protection of the constitutional order: Peter Bely spoke at the SPIEF session on intellectual property
16.08.2022
16.08.2022
Yuri Zubov, Head of the Federal Intellectual Property Service, visited the Promomed Group's Biochemist plant as part of a working trip to the Republic of Mordovia. The head of the department inspected the workshop of active pharmaceutical substances of new-generation antibiotics, the country's largest ampoule production and the company's R&D Hub, where innovative drugs are being developed.
At the meeting, Peter Bely, Chairman of the Board of Directors of Promomed Group, spoke about the intellectual potential of the company and shared plans for the development of new drugs and production facilities. The company continues to develop within the framework of the approved strategy, maintains and exceeds the pace of the announced programs. "In the new conditions, a wait–and-see attitude is not our choice. On the contrary, we are increasing our production potential, launching new workshops for both ready-made dosage forms and active pharmaceutical substances. In particular, another building for the production of full–cycle antitumor drugs in various therapeutic forms will be commissioned next year," said Petr Bely. The Chairman of the Board of Directors of Promomed Group also noted the importance of intangible assets – intellectual property objects for the company.
Yuri Zubov, Head of the Federal Intellectual Property Service, wished the Promomed team further ambitious breakthrough developments for the benefit of strengthening the health of the nation and the country's innovative potential.
Stay informed
Stay informed
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office